Procter & Gamble Health FCF Conversion
The FCF Conversion Rate (FCF/EBITDA) of Procter & Gamble Health (PGHL.NS) as of Aug 2, 2026 is 68.31 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 102.78 % — a change of -33.53% (lower).
Get this data via API
Financial Data API
FCF Conversion
68.31 %
YoY
-33.53%
Last updated:
FCF Conversion Rate (FCF/EBITDA) of Procter & Gamble Health is 2026 68.31 % . FCF Conversion Rate (FCF/EBITDA) of Procter & Gamble Health was 2025 102.78 % . It decreases by -33.53% lower compared to the previous year.
Access this data via the Eulerpool API
Procter & Gamble Health Stock analysis
What does Procter & Gamble Health do? Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion.
The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products.
The different divisions of Procter & Gamble Health Ltd. include the following areas:
Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy.
Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio.
Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area.
Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands.
Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette.
Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell.
In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide.
In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Procter & Gamble Health stock
FCF Conversion Rate (FCF/EBITDA) of Procter & Gamble Health is 68.31 % in 2026.
Access this data via the Eulerpool API
Cash Flow — Procter & Gamble Health
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Procter & Gamble Health
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth